Bulletin
Investor Alert

New York Markets Close in:

Biogen Inc.

NAS: BIIB

GO
/marketstate/country/us

Countdown to close

/zigman2/quotes/201531540/composite

$

234.51

Change

-1.60 -0.68%

Volume

Volume 1.88m

Nov 30, 2021, 3:39 p.m.

Real time quotes

/zigman2/quotes/201531540/composite

Previous close

$ 236.11

$ 234.51

Change

-1.60 -0.68%

Day low

Day high

$228.68

$239.77

Open
Open: 236.50

52 week low

52 week high

$228.68

$468.55

Open

Market cap

$34.68B

Average volume

1.05M

P/E ratio

22.86

Rev. per Employee

$1.36M

EPS

10.22

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/biib

MarketWatch News on BIIB

  1. Biogen started at outperform with $315 stock price target at BMO Capital

    8:49 a.m. Nov. 19, 2021

    - Tomi Kilgore

  2. Biogen shares slide 4% premarket

    7:41 a.m. Nov. 17, 2021

    - Ciara Linnane

  3. Biogen says its Alzheimer's treatment Aducanumab got a 'negative trend vote' from EU regulator

    7:37 a.m. Nov. 17, 2021

    - Ciara Linnane

  4. Top Biogen Executive Announces Retirement as Aduhelm Rollout Stumbles

    10:31 a.m. Nov. 16, 2021

    - Josh Nathan-Kazis

  5. Eli Lilly Earnings Disappointed. Why the Stock Is Rising.

    2:09 p.m. Oct. 26, 2021

    - Joe Woelfel

  6. Eli Lilly Is Asking the FDA to Approve Its Alzheimer's Therapy

    11:47 a.m. Oct. 26, 2021

    - Josh Nathan-Kazis

  7. Biogen stock price target cut to $390 from $450 at Oppenheimer

    7:41 a.m. Oct. 21, 2021

    - Tomi Kilgore

  8. Biogen stock price target cut to $502 from $647 at Truist

    7:30 a.m. Oct. 21, 2021

    - Tomi Kilgore

  9. Biogen shares jump 1.7% premarket

    7:27 a.m. Oct. 20, 2021

    - Ciara Linnane

  10. Biogen full-year FactSet consensus EPS of $18.49; revenue of $10.7 bln

    7:27 a.m. Oct. 20, 2021

    - Ciara Linnane

  11. Biogen now sees full-year adj. EPS of $18.85 to $19.35 vs. prior $17.50 to $19.00

    7:26 a.m. Oct. 20, 2021

    - Ciara Linnane

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/biib

Other News on BIIB

  1. Biogen drops after losing appeal to revive patent on blockbuster drug

    11:02 a.m. Today

    - Seeking Alpha

  2. 1 Cancer Stock on Buyout Watch in 2022

    9:45 a.m. Nov. 21, 2021

    - Motley Fool

  3. Ocugen Stock: Bull vs. Bear

    6:40 a.m. Nov. 20, 2021

    - Motley Fool

  4. Could Eli Lilly Leapfrog Biogen in This Market?

    6:46 a.m. Nov. 17, 2021

    - Motley Fool

  5. Cortexyme: A Challenging Path Forward

    12:06 a.m. Nov. 17, 2021

    - Seeking Alpha

  6. Loading more headlines...
/news/pressrelease/company/us/biib

Press Releases on BIIB

  1. Biogen Inc. Common Stock BIIB Investment Advice

    10:15 a.m. Nov. 17, 2021

    - Stock Traders Daily

  2. Update on Regulatory Review of Aducanumab in the European Union

    7:30 a.m. Nov. 17, 2021

    - GlobeNewswire

  3. Nasdaq 100 Movers: MELI, PTON

    2:24 p.m. Nov. 16, 2021

    - MarketNewsVideo.com

  4. Biogen Inc. Common Stock BIIB Technical Analysis

    1:15 p.m. Nov. 7, 2021

    - Stock Traders Daily

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.